Topic

Insurance Approval

A collection of 3076 issues

Oxbryta (Voxelotor) Coverage by Blue Cross Blue Shield in Illinois: 2024 FDA Withdrawal Impact and Alternative Options

Answer Box: Oxbryta Coverage Status in Illinois Oxbryta (voxelotor) was withdrawn from the US market by FDA in September 2024 due to safety concerns. Blue Cross Blue Shield of Illinois and all insurers now automatically deny coverage as the drug is no longer FDA-approved. No appeals or bridge coverage are

How to Get Lutathera (Lutetium Lu-177 Dotatate) Covered by UnitedHealthcare in California: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Lutathera Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Lutathera (lutetium Lu-177 dotatate) with step therapy documentation showing progression on somatostatin analogs. The fastest path to approval involves: 1. Submit PA request through the UnitedHealthcare Provider Portal with SSTR-positive imaging (Ga-68 DOTATATE PET/CT), pathology

How to Get Xenpozyme (olipudase alfa-rpcp) Covered by Cigna in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Xenpozyme Covered by Cigna in Washington Xenpozyme (olipudase alfa-rpcp) requires prior authorization from Cigna for ASMD (Niemann-Pick types A/B). Your fastest path: (1) Confirm genetic diagnosis with SMPD1 variants and enzyme deficiency <10% normal, (2) Have your specialist submit PA with weight-based dosing plan via

How to Get Trikafta Covered by Blue Cross Blue Shield of Michigan: Prior Authorization Forms, Appeals, and Approval Timeline

Answer Box: Getting Trikafta Covered by BCBS Michigan Blue Cross Blue Shield of Michigan requires prior authorization for Trikafta (elexacaftor/tezacaftor/ivacaftor), a specialty-tier medication for cystic fibrosis. Key requirements: CFTR genotype documentation, CF specialist prescription, and submission through Walgreens Specialty Pharmacy or Accredo. First step today: Have your CF

Do You Qualify for Duopa Coverage by Humana in Washington? Decision Tree & Next Steps

Answer Box: To qualify for Duopa coverage by Humana in Washington, you need advanced Parkinson's disease with documented motor fluctuations (≥3 hours daily OFF time) despite optimized oral therapy. Submit prior authorization with neurologist assessment, failed treatment history, and surgical candidacy documentation. If denied, use Humana's

Renewing Xyrem (Sodium Oxybate) Approval with Humana in North Carolina: 2025 Requirements and Timeline

Quick Answer: Xyrem Renewal with Humana in North Carolina Start your Xyrem renewal 30-45 days before expiration. Humana requires updated clinical documentation, evidence of continued medical necessity, and REMS program compliance. If denied, you have 65 days to appeal through Medicare's federal process (not North Carolina's

Oxbryta (Voxelotor) Coverage by Aetna CVS Health in California: 2024 FDA Withdrawal and Your Treatment Options

Answer Box: Oxbryta (Voxelotor) Status and Next Steps Oxbryta (voxelotor) was voluntarily withdrawn from all U.S. markets in September 2024 due to safety concerns. Aetna CVS Health and all insurers no longer authorize this medication. If you were taking Oxbryta, contact your hematologist immediately to discuss alternatives like hydroxyurea,

The Requirements Checklist to Get Aldurazyme (Laronidase) Covered by Cigna in Texas

Quick Answer: Getting Aldurazyme Covered by Cigna in Texas Eligibility: Patients with confirmed mucopolysaccharidosis I (MPS I) via genetic/biochemical testing. Fastest approval path: Submit complete prior authorization with genetic confirmation, baseline assessments, and specialist attestation through Cigna's provider portal or Express Scripts/Accredo. First step today: Contact

How to Get Nucala (Mepolizumab) Covered by Blue Cross Blue Shield of California: 2024 Prior Authorization Guide

Answer Box: Getting Nucala Covered by Blue Shield of California Blue Shield of California requires prior authorization for Nucala (mepolizumab) with specific criteria: eosinophil count >150 cells/µL (6 weeks) or >300 cells/µL (12 months), failed high-dose inhaled corticosteroids plus controller for 3+ months, and prescription by

How Long Does It Take to Get Sylvant (Siltuximab) Approved by Aetna (CVS Health) in Virginia? Complete Timeline & Appeals Guide

Answer Box: Getting Sylvant (Siltuximab) Covered by Aetna (CVS Health) in Virginia Timeline: Aetna (CVS Health) typically decides prior authorization requests for Sylvant (siltuximab) within 14-30 days for standard cases, or 72 hours for urgent requests. After approval, CVS Specialty coordinates the first fill within 2-5 business days. Fastest path: